Correction: Waldenström macroglobulinemia treatment algorithm 2018 (Blood Cancer Journal, (2018), 8, 4, (40), 10.1038/s41408-018-0076-5)

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following the publication of this article the authors noted that the sentence on page 5 reading “The major response rate was 80% with no difference between patients with wild-type or mutated MYD 88” was incorrect, and should read as “The major response rate was 80% with no difference between patients with mild-type or mutated CXCR4”. The authors wish to apologise for any inconvenience caused. This has now been corrected in the HTML and PDF.

Original languageEnglish (US)
Article number53
JournalBlood cancer journal
Volume9
Issue number7
DOIs
StatePublished - Jul 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Correction: Waldenström macroglobulinemia treatment algorithm 2018 (Blood Cancer Journal, (2018), 8, 4, (40), 10.1038/s41408-018-0076-5)'. Together they form a unique fingerprint.

Cite this